paroxetine mesylate / Generic mfg.  >>  Phase 3
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
paroxetine mesylate / Generic mfg.
NCT00836069: Fixed Dose Study of PD 0332334 and Paroxetine for the Treatment of Generalized Anxiety Disorder

Terminated
3
5
US
No drug name provided by Sponsor; drug referenced as PD 0332334, Paroxetine, Paxil, Paxil CR, Brisdelle, and Pexeva, Placebo
Cedars-Sinai Medical Center, Pfizer
Anxiety Disorders
02/09
04/10
NCT01101841: 24-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms

Completed
3
570
US
Brisdelle (paroxetine mesylate), Former Names: Mesafem Capsules or, LDMP (Low-Dose Mesylate salt of Paroxetine), Placebo capsules, Sugar pill
Noven Therapeutics
Hot Flashes
09/11
11/11
NCT01361308: Efficacy/Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms (VMS)

Completed
3
614
US
Brisdelle (paroxetine mesylate), Former Names: Mesafem Capsules or, LDMP (Low-Dose Mesylate salt of Paroxetine), Placebo capsules, Sugar pill
Noven Therapeutics
Postmenopausal Symptoms
12/11
02/12

Download Options